文献速递关节外科

钙卫蛋白即时检测诊断全膝关节置换术后假体周围感染的前瞻性队列研究

Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection After Total Knee Arthroplasty: A Prospective Cohort Study.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

该前瞻性队列研究纳入123例翻修全膝关节置换术患者,以2013年MSIS标准为金标准,评估滑液钙卫蛋白即时检测(POC)对假体周围感染(PJI)的诊断价值。结果显示,在≥50 mg/L阈值下,敏感性98.1%、特异性95.7%、AUC 0.969;在≥14 mg/L阈值下,敏感性98.1%、特异性87.1%、AUC 0.926。钙卫蛋白POC检测具有优异的PJI诊断性能,可作为排除性检测。

要点

  • 钙卫蛋白POC检测在翻修TKA患者中诊断PJI的敏感性达98.1%。
  • ≥50 mg/L阈值下特异性95.7%,AUC 0.969,性能优异。
  • 该检测可作为PJI的排除性工具,但需更大样本验证。

核心结论

  • 钙卫蛋白即时检测在翻修全膝关节置换术患者中具有优异的PJI诊断特性,包括高敏感性和特异性。
  • 该检测可有效作为排除性检测使用,但需更大队列研究验证。

研究设计与样本

  • 以2013年MSIS PJI诊断标准为金标准,由2名独立且对钙卫蛋白结果不知情的评审者分类为感染或无菌性翻修。
  • 证据等级为诊断Level I。

主要发现

  • 根据MSIS标准,53例翻修TKA为感染性,70例为无菌性。
  • 在≥50 mg/L阈值下,敏感性98.1%、特异性95.7%、阳性预测值94.5%、阴性预测值98.5%、AUC 0.969。
  • 在≥14 mg/L阈值下,敏感性98.1%、特异性87.1%、阳性预测值85.2%、阴性预测值98.4%、AUC 0.926。

关键数值与推荐

  • 以2013年MSIS标准为PJI诊断金标准。
  • 评估了两个钙卫蛋白阈值:≥50 mg/L和≥14 mg/L。

临床怎么用

  • 钙卫蛋白POC检测可用于翻修TKA患者中PJI的排除性诊断,高阴性预测值支持其排除感染的能力。

局限性

  • 需要更大队列的进一步研究来验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite several synovial fluid biomarkers for the diagnosis of periprosthetic joint infection (PJI) having been investigated, point-of-care (POC) tests using these biomarkers are not widely available. Synovial calprotectin has recently been reported to effectively exclude the diagnosis of PJI. Thus, the objective of this study was to test the value of a calprotectin POC test for PJI diagnosis in patients undergoing total knee arthroplasty (TKA) using the 2013 Musculoskeletal Infection Society (MSIS) PJI diagnosis criteria as the gold standard. METHODS: Synovial fluid samples were prospectively collected from 123 patients who underwent revision TKA at 2 institutions within the same health-care system from October 2018 to January 2020. The study was conducted under institutional review board approval. Data collection comprised demographic, clinical, and laboratory data in compliance with the MSIS criteria. Synovial fluid samples were analyzed by calprotectin POC tests in accordance with the manufacturer's instructions. Revisions were categorized as septic or aseptic using MSIS criteria by 2 independent reviewers blinded to the calprotectin results. Calprotectin test performance characteristics with sensitivities, specificities, positive predictive values, negative predictive values, and areas under the receiver operating characteristic curve (AUC) were calculated for 2 different PJI diagnosis scenarios: (1) a threshold of ≥50 mg/L, and (2) a threshold of ≥14 mg/L. RESULTS: According to the MSIS criteria, 53 revision TKAs were septic and 70 revision TKAs were aseptic. In the ≥50-mg/mL threshold scenario, the calprotectin POC performance showed a sensitivity of 98.1%, a specificity of 95.7%, a positive predictive value of 94.5%, a negative predictive value of 98.5%, and an AUC of 0.969. In the ≥14-mg/mL threshold scenario, the sensitivity was 98.1%, the specificity was 87.1%, the positive predictive value was 85.2%, the negative predictive value was 98.4%, and the AUC was 0.926. CONCLUSIONS: The calprotectin POC test has excellent PJI diagnostic characteristics, including high sensitivity and specificity in patients undergoing revision TKA. This test could be effectively implemented as a rule-out test. However, further investigations with larger cohorts are necessary to validate these results. LEVEL OF EVIDENCE: Diagnostic Level I. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Warren J, Anis HK, Bowers K, et al. Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection After Total Knee Arthroplasty: A Prospective Cohort Study. J Bone Joint Surg Am. 2021. PMID: 34038396. doi:10.2106/JBJS.20.01089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。